Conference Objectives
- Provide current and high-quality information on the latest developments in the management of lymphoproliferative disease
- Create collegial learning opportunities to enable clinicians to share real-world experience and to directly apply new insights to their practice
- Foster discussions that allow for the sharing of knowledge and experience among delegates and industry representatives
- Respond to emerging professional needs for specific and in-depth information on the latest therapies for lymphoproliferative disease in the Canadian market
Scientific Steering Committee
The scientific steering committee for the Toronto Lymphoma Conference 2025 includes Dr. John Kuruvilla and Dr. Peter Anglin.
John Kuruvilla, MD, FRCPC
Dr. John Kuruvilla is a Professor of Medicine at the University of Toronto and a hematologist in the Division of Medical Oncology and Hematology at the Princess Margaret Cancer Centre in Toronto. He is a member of the Lymphoma, Autologous Transplant and Immune Effector Cell Therapy programs. Dr. Kuruvilla’s research interest is the development of novel therapeutics in lymphoid malignancies and incorporating translational research into clinical trials. He is the Lymphoma Co-Chair for the Canadian Cancer Trials Group (CCTG) as well as the Chair of the Scientific Advisory Board of Lymphoma Canada.
Peter Anglin, MD, MBA, FRCPC
Dr. Peter Anglin’s clinical focus remains in haematologic and lymphoid malignancies. He is currently Physician Lead for the Stronach Regional Cancer Centre in Newmarket, Ontario. He has also developed an interest in health systems delivery, process redesign in the ambulatory setting, and optimizing drug access for oncology patients. He continues to serve in an advisory capacity to a number of pharmaceutical and health-related organizations. He remains the medical director of CarePath, a cancer navigation and support service supporting Cancer Care Ontario and Ontario cancer patients.
Conference Agenda
The Toronto Lymphoma Conference 2025 is a full day of in-person education and networking, with sessions on new and emerging innovations in treating and managing lymphoproliferative disease in Canada.
Time
Session
Speaker
8:30 - 8:45 AM
Welcome & Opening Remarks
Peter Anglin
8:45 AM–9:15 AM
Sponsored Breakfast Symposium (FORUS Therapeutics)
Darrell White
9:15 AM–9:45 AM
CAR-T and Bispecifics in MM in 2025: Who, When, and Where
Christine Chen
9:45 AM–10:15 AM
Amyloid in 2025: Treatment and Management Considerations
Victor Zepeda
10:15 AM–10:45 AM
Emerging therapies in CLL: ncBTKi, cellular therapy, T-cell therapies
Matthew Davids
10:45 AM–11:00 AM
Networking Break
ALL
11:00 AM–11:30 AM
Second line approaches in DLBCL
Nancy Bartlett
11:30 AM–12:00 PM
CAR-T and Bispecifics in 2025 in rrFL: Who, When, and Where
Gilles Salles
12:00 PM–1:15 PM
LUNCH
ALL
1:15 PM–1:45 PM
Sponsored Lunch Symposium (Eli Lilly Canada)
TBD
1:45 PM- 2:15 PM
Primary therapy for MCL in 2025
John Kuruvilla
2:15 PM- 2:45 PM
Management of the limited stage HL Patient in 2025
Michael Crump
2:45 PM- 3:10 PM
Networking Break
ALL
3:10 PM- 3:40 PM
Primary mediastinal large B-cell lymphoma
Kieron Dunleavy
3:40 PM- 4:10 PM
Secondary immunodeficiency in hematologic malignancy: What to do?
Jeannie Callum
4:10 PM- 4:15 PM
Closing Remarks & Adjournment
John Kuruvilla
4:15 PM- 6:00 PM
Cocktail Reception
ALL
Our Sponsors
Founder's Level
Gold
Silver
Bronze
Subscribe To Canadian Hematology Today
Canadian Hematology Today provides a forum for the clinical community to share real-world experience and the latest best practices in the treatment and management of hematologic disease.
The journal is published thrice yearly in English and French and is circulated to over 1,100 hematology clinicians and researchers across Canada. It features peer-reviewed articles that present robust clinical perspectives and practical insights into disease management.
About Catalytic Health
Founded in 2009, Catalytic Health is one of Canada’s largest medical education agencies and reaches over 50,000 Canadian clinicians a year with its educational programs, services and platforms. Catalytic Health is also the largest independent medical publisher in Canada, one of the largest scientific conference providers, and a leader in innovative events and services for the Life Sciences industry. Learn more about Catalytic Health.
© 2025 All Rights Reserved.